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Objective. The main goal of this project was to establish content validity and describe internal consistency of a patient
counseling competency assessment instrument used to evaluate student pharmacists practicing in an oncology setting.
Methods. A modified e-Delphi panel of oncology clinical pharmacy specialists, clinical pharmacy generalists, and
oncology pharmacy residents was employed. Iterative rounds of the e-Delphi process were conducted until consensus was
reached on a majority of the instrument items. Consensus was defined as agreement by at least 75% of participants that an
item was, or was not important. Internal consistency of defined sections of the instrument was determined using Cronbach
alpha.
Results. The modified e-Delphi process included three rounds of responses from 13 panelists and resulted in a 35-item
instrument with consensus reached on 33/35 (94%) of the items, and a Cronbach alpha of 0.95. All participants indicated
that the assessment result options allowed them to indicate the student’s level of competency either extremely well or very
well.
Conclusion. A modified e-Delphi method used to validate a reliable instrument for the assessment of student pharmacist
counseling abilities in the oncology setting. Similar methodology should be considered during the development of student
assessment tools, especially for high impact student pharmacist activities such as chemotherapeutic medication
counseling.
Keywords: content validity, patient counseling, assessment, student pharmacists

INTRODUCTION
Student pharmacists are important resources allowing an extension of the clinical pharmacist workforce. In 2011,
the Pharmacy Practice Model Initiative (PPMI) of the American Society of Health-System Pharmacists called for
increased involvement of student pharmacists in drug therapy management services.1,2 Educating patients regarding the
appropriate use of medications is also a core entrustable professional activity for new pharmacy graduates.3 Student
pharmacists have carried out increasingly complex functions, moving from observers to integral members of the care
team. Delgado and colleagues reported on student pharmacists as part of a layered learning model in an acute care setting,
which included patient counseling at discharge and for targeted disease states.4 The student pharmacists allowed for
expansion of pharmacy services to patients who would not otherwise have such interactions with a pharmacist. During
experiential education, student pharmacists not only gain valuable experience, but also provide important clinical services
to patients.
Student pharmacists completing clinical rotations (advanced pharmacy practice experiences, or APPEs) at The
Johns Hopkins Hospital (JHH) are expected to provide patient counseling. Preceptors ensure each student pharmacist is
sufficiently prepared and able to counsel patients as early as possible in the rotation. To promote autonomy, student
pharmacists at JHH undergo patient counseling competency assessments, which cover topics relevant to their APPE (eg,
internal medicine topics such as diabetes management, opioids and naloxone, and proper use of inhalers; oncology topics
such as prophylactic antimicrobials and immunosuppressants for hematopoietic stem cell transplantation [HSCT]). Using
a role-playing approach, the preceptor determines if the student is competent to counsel independently, requires
supervision while counseling, or must repeat the assessment.
While our institution has developed instruments to evaluate student counseling competency for targeted topics,
there is currently no validity evidence to support their use. In general, there is a lack of published work describing validity
evidence of instruments used to assess the readiness of student pharmacists to provide patient counseling in oncology. Lin
and colleagues established validity evidence for an instrument used to evaluate pharmacists providing counseling on
1
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METHODS
In order to evaluate the content validity of the assessment instrument, a modified e-Delphi panel process was
conducted. Participants were 13 oncology clinical pharmacy specialists, generalists, and residents at JHH. This group
included all known individuals within the oncology practice area of the institution who had both content expertise and
experience with assessing student pharmacists for counseling activities. The project was approved by the Institutional
Review Boards at Johns Hopkins Medicine.
The Delphi process is a method of systematically determining consensus among experts, consisting of several
rounds of surveys or consultations.7 The use of the e-Delphi process (referring to an electronic version) has been
described8 and applied in several health care fields.9–12 Advantages of e-Delphi over traditional Delphi include the ability
to maintain anonymity of panelists, the convenience of collecting responses for investigators and panelists, and the ability
to include panelists in locations that may not be convenient or feasibly visited by the investigator.13 Several Delphi panels,
in the traditional or modified form, have been conducted in academic and experiential pharmacy practice settings, and
have focused on patient counseling, definition of competencies, and curriculum design.7,14–18
The topic for which the instrument was assessed is “immunosuppressants for patients undergoing HSCT.” The
study began with distribution of an electronic survey (Qualtrics, Provo, UT) to all panelists for e-Delphi round 1 (N = 13).
Basic non-identifying descriptive data were captured, including role/job title and years of experience. In the main portion
of the survey, panelists were asked to evaluate each item of the assessment instrument in use at the practice site. Panelists
were asked to rate the level of importance of each item on a five-point Likert scale, and to suggest the removal of existing
items or addition of new items. The estimated response time for the survey was 6-10 minutes. Panelists were asked to
answer the questionnaire within 15 business days, at which point weekly email reminders were sent for an additional two
weeks.
There were three of instrument evaluation conducted by the expert panel. After each round, responses were
summarized, and the next round began with delivery of the summarized, anonymous responses to each panelist. Each
panelist then reviewed the summarized data, compared it to their own responses, and responded to the survey in the next
round. In round 1, free-text response questions were included after each survey section asking the participant if they
would add any new items, or modify existing items. In round 2, panelists were presented with a summary of the free-text
responses and asked if they categorically agreed or disagreed with the proposed change. If consensus was reached, the
changes were made and incorporated into the round 3 survey. After rounds 1 and 2, if consensus was reached that an item
was unimportant, the item was removed in the subsequent survey. The final revised instrument was shared with all
panelists.
The a priori definition of consensus for this analysis was at least 75% of panelists having similar observations.
For example, at least 75% of participants needed to report an item was “extremely important” or “very important” (scores
of 5 and 4 on the Likert scale, respectively) for consensus to be reached that the item was important. Conversely, at least
75% of participants need to report an item was “slightly important” or “not at all important” for consensus to be reached
that the item is not important. Reliability of responses in each round was described by Cronbach alpha, which has
previously been applied in Delphi studies.19–21 Aggregate data were downloaded from Qualtrics and stored on a secure
drive hosted by Johns Hopkins. Statistical analyses were conducted using Stata/IC 13 (StataCorp LLC, College Station,
TX).
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herbal and dietary supplements.5 After initial creation of the instrument, pharmacists determined that the instrument
demonstrated favorable reliability and construct validity. Another description of validity and reliability evidence in
pharmacy education was reported by Zhou and colleagues, regarding preceptor assessment of student pharmacist
performance on clinical rotations.6 While these works are important and provide a useful framework, they are not specific
to the oncology setting.
The existing institution-specific counseling competency assessment instruments have been used for several years.
While they are perceived as valuable among preceptors, there has not yet been a formal evaluation of the validity, content,
or structure of the assessment instruments. As student pharmacists are a critical part of the pharmacy workforce and allow
the pharmacy team to counsel more patients, it is important to ensure that the assessment instruments accurately reflect
intended content and have the support of preceptors.
The main goal of this project was to validate the instrument to ensure the delivery of high-quality, effective, and
relevant patient counseling. A secondary goal was to develop a framework to validate assessment instruments for other
topics in oncology and internal medicine. The main objective was to evaluate the content validity of the assessment
instrument through an e-Delphi panel of experts involved in conducting the counseling competency assessments.
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DISCUSSION
Student pharmacists are capable of undertaking complex tasks including patient counseling. While standardized
instruments have been used to evaluate the competency of student pharmacists to counsel patients at our institution for
several years, the validity and internal consistency of the instruments had not been evaluated, nor were previously
validated tools available in the literature. The authors believe applying a consistent approach to the training and
assessment of student pharmacists is important to ensuring delivery of consistent, high-quality patient education. This
report demonstrates the feasibility of conducting a modified e-Delphi process to establish content validity
and reliability of an instrument used to assess student pharmacist counseling competency.
Content validity was established by iterative rounds of consensus decision making, as outlined by others. Internal
consistency was evaluated by calculation of Cronbach alpha. The final assessment instrument yielded an alpha of 0.95,
ranging from 0.69 to 0.94 among sections of the instrument, indicating very good internal consistency.
The clinical content for this effort was immunosuppressive agents used for prophylaxis of graft rejection and
graft-versus-host disease for patients undergoing allogeneic hematopoietic cell transplantation at our institution. This topic
was chosen due to its overall complexity, including multiple medications, compared with other existing topics. Thus, it
may not be readily generalizable to other institutions. However, it serves as a proof of concept for those using similar
approaches to determining competency of student pharmacists providing patient counseling. While most participants had
experience using the instrument, several years elapsed between original implementation and this work, including staff
turnover, which we believe allowed for objective participation. It is expected that previous experience assessing students
with the instrument also provided valuable context and subject matter expertise in which participants considered necessary
changes.
The modified e-Delphi method was straightforward in its design and application, using survey software and email
communication. The modified e-Delphi process may be prohibitively labor-intensive to apply to all of the various
topics on which student pharmacists may be assessed. It may be most useful to use this approach to establish validity
of complex topics, or those for which there is subjective controversy; then, employ the institution specific framework to
revise the assessment of other, more straightforward topics. The high participation rate for our surveys indicates that
stakeholders had a clear interest in ensuring the appropriateness of the instrument. However, it may become burdensome
to repeat the process several times. Students are currently assessed on topics chosen at the discretion of their preceptor,
based on the needs of patients during the rotation. This creates an opportunity for specific groups of preceptors to focus on
topics that may be most relevant to their practice area.
The revised instrument is now used for assessment of student pharmacists. Future directions for this
research include applying the modified e-Delphi process to other assessment instruments for student pharmacists at our
institution. By establishing validity of one specialized instrument, additional instruments may undergo a similar process in
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RESULTS
The response rate for round 1 was 92% (n = 12). Participants included five current clinical specialists (38% of
total), three current PGY2 oncology pharmacy residents (23%), three current pharmacist generalists (23%), and 2 clinical
specialists formerly employed by the institution (15%). The average duration of pharmacist experience was 7 years (range
1 to 16), and average duration of oncology experience was 6 years (range 1 to 15). Most participants had previous
experience administering the counseling assessment on hematopoietic cell transplantation (HCT)(58%) or other topics
(25%).
In round 1, consensus was reached for 29 of 32 items; overall Cronbach alpha was 0.87. The three non-consensus
items were re-evaluated in round 2, after participants reviewed the summary results. A total of 21 suggestions for changes
to the proposed instrument items were submitted.
In round 2, consensus was reached for 26 of 32 items, with 69% participation (n=9). Of the six items that did not
reach consensus, five items were removed and one revised based on qualitative feedback. Additional questions were
added seeking consensus on the addition, removal, or change of items from round 1, based on the descriptive comments
received. Consensus was reached for 16 of 21 proposed changes, which were incorporated into the round 3 survey. In this
iteration the Cronbach alpha was 0.93. Of the four comments submitted in round 2, none resulted in substantive changes
to the survey items.
The round 3 survey had a 100% participation rate (n = 13) and demonstrated consensus in all but 2 items
regarding the goal serum concentration ranges for tacrolimus and sirolimus, which on further review, were deemed to be
important inclusions by the investigators and remained in the final assessment instrument (Table 1). The modified eDelphi process resulted in a 35-item instrument (Figure 1) with consensus reached on 33/35 (94%) of the items, and a
Cronbach alpha of 0.95. All participants indicated that the assessment result options allowed them to indicate the student’s
level of competency either extremely well or very well.

3

CONCLUSION
A modified e-Delphi method was employed to establish content validity and internal consistency of a frequently
used assessment instrument for student pharmacists participating in patient counseling in oncology. While the end result is
an improved assessment instrument for counseling patients on immunosuppression for HCT, this work also serves as a
proof of concept and feasibility study. The modified e-Delphi method may be used to establish content validity for
assessment instruments in other areas of patient counseling, including content areas that may be complex or controversial.
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Table 1. Summary of e-Delphi Round 3 Responses
Item
Median score
Range
General Patient Education
1.1
1
1--2
1.2
1
1--2
1.3
1
1--3
1.4
1
1--2
1.5
2
1--3
1.6
2
1--3
1.7
1
1--2
1.8
1
1--2
Immunosuppression General Information
2.1
1
1--2
2.2
1
1--3
2.3
1
1--2
2.4
1
1--2
2.5
1
1--4
2.6
1
1--2
2.7
1
1--2
2.8
1
1--2
2.9
1
1--2
2.10
1
1--2
2.11
1
1--2
2.12
1
1--2
2.13
1
1--2
Importance of Follow-Up
3.1
2
1--3
3.2
2
1--3
3.3
1
1--2
3.4
1
1--2
Drug-Drug Interactions
4.1
1
1--4
4.2
1
1--2
4.3
1
1--2
Drug-Food Interactions
5.1
1
1--2
Side Effects
6.1
1
1--2
6.2
1
1--2
6.3
1
1--2
6.4
2
1--2
6.5
2
1--2
Final Assessment
7.1
2
1--2
All items
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0.936

n/a
0.947

Figure 1. Learner Competency for Hematopoietic Stem Cell Transplant Immunosuppression
Category
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General Patient
Education

Essential Components









Correctly identifies the patient
Introduces self
Explains purpose of education
Uses plain language and medical terms the patient can understand
Uses open-ended questions
Asks patient to explain in their own terms what was understood using teach-back questions
Identifies gaps in understanding and provides clarification
Answers questions within their scope, defers to physician or pharmacist when appropriate

Importance of
Follow-up






Drug-Drug
Interactions

 MMF: supplements that contain calcium, aluminum, magnesium, or iron
 Tacrolimus: certain antifungals, blood pressure medications, and herbal medications
 Tells patient to ask provider before starting new medications or stopping any medications as
there may be impact on immunosuppressant drug levels

Drug-Food
Interactions

 Tacrolimus: avoid grapefruit, Seville orange, star fruit

Side Effects

 MMF: nausea, vomiting or diarrhea
 Tacrolimus: Mild tremors/shakiness, high heart rate or blood pressure, high blood sugar,
changes in vision, kidney problems; may require additional medications to manage
 Sirolimus: swelling, high cholesterol or triglycerides, sore muscles or joints, mouth sores
 Providers will be monitoring for side effects
 List presented here not all-inclusive; report any new symptoms to provider

Final Assessment

 Student is competent to counsel without observation
 Student should be observed prior to counseling on his/her own
 Student needs additional practice with a preceptor prior to counseling on his/her own
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Immunosuppression
General Information

 Choose the correct counseling handout
 Reviews indication (prevention of GVHD and graft rejection)
 Reviews dosing and administration for MMF
 Three times daily
 1 hour before or 2 hours after or any supplements that contains calcium, aluminum,
magnesium, or iron including antacids
 Taken from Day +5 through Day +35 (31 days total)
 Reviews dosing and administration for tacrolimus
 If PO, q 12 hours, consistently with or without food; if IV, daily
 Starts Day +5 and continues for 2 to 6 months after transplant. Do not stop until
instructed.
 Brand and generic tacrolimus are not be interchanged
 Reviews dosing and administration for sirolimus
 Taken daily
 Starts Day +5 and continues for 2 to 6 months after transplant. Do not stop until
instructed.
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Tacrolimus goal (typically 10-15 ng/mL); provider may change goal
Sirolimus goal (typically 5-15 ng/mL); provider may change goal
Explains reasons behind importance of keeping appointments for lab draws
Reminds patient not to take morning dose when in clinic on the day levels are to be drawn
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